Coherus BioSciences, Inc.
CHRS
$0.7818
-$0.0349-4.27%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 125.99M | 97.69M | 159.24M | 259.78M | 117.75M |
| Total Receivables | 122.33M | 198.80M | 313.57M | 284.15M | 260.52M |
| Inventory | 70.09M | 47.64M | 62.16M | 61.98M | 62.61M |
| Prepaid Expenses | 23.17M | 24.89M | 22.96M | 21.58M | 34.76M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 341.58M | 369.02M | 557.93M | 627.48M | 475.63M |
|
|
|||||
| Total Current Assets | 341.58M | 369.02M | 557.93M | 627.48M | 475.63M |
| Net Property, Plant & Equipment | 7.36M | 2.91M | 3.33M | 4.19M | 11.03M |
| Long-term Investments | -- | -- | -- | -- | 943.00K |
| Goodwill | -- | -- | -- | -- | 943.00K |
| Total Other Intangibles | 53.65M | 54.31M | 55.46M | 57.10M | 70.73M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 45.95M | 78.75M | 58.14M | 74.78M | 71.27M |
| Total Assets | 448.53M | 505.00M | 674.86M | 763.55M | 629.60M |
|
|
|||||
| Total Accounts Payable | 28.46M | 21.89M | 76.82M | 38.29M | 35.22M |
| Total Accrued Expenses | 227.04M | 227.03M | 239.33M | 292.43M | 291.11M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.84M | 3.81M | 4.12M | 176.81M | 2.15M |
| Total Finance Division Other Current Liabilities | 24.65M | 42.84M | 142.74M | 30.77M | 3.30M |
| Total Other Current Liabilities | 24.65M | 42.84M | 142.74M | 30.77M | 3.30M |
| Total Current Liabilities | 282.98M | 295.57M | 463.01M | 538.30M | 331.77M |
|
|
|||||
| Total Current Liabilities | 282.98M | 295.57M | 463.01M | 538.30M | 331.77M |
| Long-Term Debt | 292.52M | 291.94M | 290.06M | 299.67M | 473.37M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 3.29M | 3.74M | 4.17M | 4.68M | 5.33M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.73M | 1.73M | 1.73M | 2.73M | 12.56M |
| Total Liabilities | 580.52M | 592.97M | 758.96M | 845.39M | 823.03M |
|
|
|||||
| Common Stock & APIC | 1.42B | 1.41B | 1.41B | 1.40B | 1.39B |
| Retained Earnings | -1.55B | -1.50B | -1.49B | -1.48B | -1.58B |
| Treasury Stock & Other | -275.00K | -275.00K | -272.00K | -272.00K | -248.00K |
| Total Common Equity | -131.99M | -87.97M | -84.11M | -81.84M | -193.43M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -131.99M | -87.97M | -84.11M | -81.84M | -193.43M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -131.99M | -87.97M | -84.11M | -81.84M | -193.43M |
|
|
|||||
